Clicky

Saturday, November 7, 2026

Breaking News

Latest SEC filings as they come in

Tal Cohen Files Form 144 to Sell Shares of NASDAQ, Inc.

Tal Cohen has filed to sell 2,286 shares of NASDAQ, Inc., valued at approximately $250,088.40, reflecting ongoing market activity.

BofA Finance LLC Files Preliminary Term Sheet for Notes

BofA Finance LLC has filed a preliminary term sheet for Accelerated Return Notes linked to technology stocks, signaling a strategic move in structured products.

Stewards, Inc. Files Prospectus Supplement for Note Offering

Stewards, Inc. updates investors on a $22M convertible promissory note offering in a new prospectus supplement, signaling strategic financing efforts.

Welch & Forbes LLC reports $8.34 billion in holdings

Welch & Forbes LLC disclosed $8.34 billion in assets under management in its latest filing, reflecting strategic investment decisions in the financial sector.

BofA Finance LLC files pricing supplement for new notes

BofA Finance LLC has filed a pricing supplement for its new yield notes, linked to the S&P 500 Futures index, fully guaranteed by Bank of America.

Pitofsky files to sell 3,883 shares of Regeneron Pharmaceuticals

Jason Pitofsky plans to sell 3,883 shares of Regeneron Pharmaceuticals, valued at about $3.79 million, reflecting trends in executive stock sales.

Hilton Worldwide notifies NYSE of stock delisting plans

Hilton Worldwide has filed to remove its common stock from the NYSE, indicating a strategic shift that may affect the hotel industry.

GS Finance Corp. files for $2.665 million in autocallable notes

GS Finance Corp. has filed a registration statement for $2.665 million in autocallable notes linked to the S&P 500 Futures index, highlighting market strategy.

FLYNN ZITO CAPITAL MANAGEMENT Reports $378.94M in Holdings

FLYNN ZITO CAPITAL MANAGEMENT, LLC disclosed its holdings valued at $378.94 million in its latest SEC filing, showcasing its investment strategy.

Oxford Lane Capital Corp. announces $40M note redemption

Oxford Lane Capital Corp. plans to redeem $40 million in 5.00% Notes due 2027, effective December 4, 2026, as part of its financial strategy.

BofA Finance LLC Unveils New Callable Yield Notes

BofA Finance LLC files for new Callable Yield Notes linked to major indices, aiming to attract investors with a 10% coupon rate.

Beyond Retail Equity LLC Files New Debt Offering Under Rule 506(b)

Beyond Retail Equity LLC has filed a new debt offering to raise funds, indicating a strategic move in the competitive real estate market.

Citigroup unveils new Step Down Trigger Autocallable Notes

Citigroup Inc. announces a new offering of Step Down Trigger Autocallable Notes linked to major indices, enhancing its financial product offerings.

Mainstay Income Opportunity Fund II seeks $20M in private offering

Mainstay Income Opportunity Fund II, LLLP files to raise $20 million through a private offering, emphasizing a strategic focus on accredited investors.

Barclays Bank announces Buffered Autocallable Notes offering

Barclays Bank PLC files for new Buffered Autocallable Notes, enhancing capital structure and offering investors unique investment opportunities.

Red Cedar Investment Management reports $1B in holdings

Red Cedar Investment Management, LLC has reported a portfolio exceeding $1 billion as of September 30, 2026, reflecting its investment strategy in major companies.

Capital One CEO Fairbank to Sell 90,743 Shares of Stock

Capital One CEO Richard D. Fairbank files to sell 90,743 shares of common stock, reflecting ongoing executive stock management strategies.

Tybourne Capital Management updates ownership in Forte Biosciences

Tybourne Capital Management files Schedule 13G/A, showing no beneficial ownership in Forte Biosciences, indicating a potential shift in investment strategy.

BlackRock Increases Stake in Wyndham Hotels to 10%

BlackRock, Inc. boosts its ownership in Wyndham Hotels & Resorts to 10%, signaling strategic interest in the hospitality sector.

BlackRock Reports 10% Stake in BioMarin Pharmaceutical Inc.

BlackRock, Inc. files amended Schedule 13G, revealing a 10% stake in BioMarin Pharmaceutical Inc., emphasizing its influence in the pharmaceutical sector.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →